These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23279656

  • 1. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A, Craig M, Hamadani M, Abraham J, Hobbs GR, Sarwari AR.
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [Abstract] [Full Text] [Related]

  • 2. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M, Cumpston AD, Hobbs GR, Devetten MP, Sarwari AR, Ericson SG.
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [Abstract] [Full Text] [Related]

  • 3. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
    Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Kamimura T, Shimono N, Akashi K.
    PLoS One; 2013 Jun; 8(1):e54190. PubMed ID: 23372683
    [Abstract] [Full Text] [Related]

  • 5. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    Khan MA, Siddiqui BK, Shamim A, Yosuf MA, Ahmed U, Zakiullah N, Burney IA.
    J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
    [Abstract] [Full Text] [Related]

  • 6. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
    Chong Y, Yakushiji H, Ito Y, Kamimura T.
    Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
    [Abstract] [Full Text] [Related]

  • 7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R, Estaitieh N, Mugharbil A, Jisr T, Abdallah DI, Ziade F, Sinno L, Ibrahim A.
    Front Cell Infect Microbiol; 2015 Apr; 5():11. PubMed ID: 25729741
    [Abstract] [Full Text] [Related]

  • 8. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo-Domenech E, Jiménez L, Carratalà J.
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [Abstract] [Full Text] [Related]

  • 9. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L, Brown M, Sasadeusz J, MacGregor L, Grigg AP.
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [Abstract] [Full Text] [Related]

  • 10. [Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
    Leibson T, Ben-Shimol S, Hazan G, Fruchtman Y, Kapelushnik J, Greenberg D.
    Harefuah; 2012 Oct; 151(10):592-6, 603-4. PubMed ID: 23316669
    [Abstract] [Full Text] [Related]

  • 11. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
    Figuera Esparza M, Carballo M, Silva M, Figueredo A, Avilán J.
    Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
    [Abstract] [Full Text] [Related]

  • 12. Bacteremia in febrile cancer patients in Uganda.
    Lubwama M, Phipps W, Najjuka CF, Kajumbula H, Ddungu H, Kambugu JB, Bwanga F.
    BMC Res Notes; 2019 Jul 30; 12(1):464. PubMed ID: 31362783
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö, Zarakolu P, Aşçioğlu S, Etgül S, Uz B, Büyükaşik Y, Akova M.
    Infect Dis (Lond); 2015 Jul 30; 47(10):686-93. PubMed ID: 26024284
    [Abstract] [Full Text] [Related]

  • 14. Surveillance study of bacteraemic episodes in febrile neutropenic children.
    Ariffin H, Navaratnam P, Lin HP.
    Int J Clin Pract; 2002 May 30; 56(4):237-40. PubMed ID: 12074201
    [Abstract] [Full Text] [Related]

  • 15. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
    Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R.
    BMC Infect Dis; 2008 Jun 09; 8():80. PubMed ID: 18541017
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit.
    Cadena J, Taboada CA, Burgess DS, Ma JZ, Lewis JS, Freytes CO, Patterson JE.
    Bone Marrow Transplant; 2007 Jul 09; 40(2):151-5. PubMed ID: 17530005
    [Abstract] [Full Text] [Related]

  • 17. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S, Cetingül N, Kantar M, Karapinar D, Kavakli K, Kansoy S.
    Pediatr Hematol Oncol; 2004 Mar 09; 21(2):115-23. PubMed ID: 15160510
    [Abstract] [Full Text] [Related]

  • 18. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S, Palmer S, Ellis-Pegler R.
    Intern Med J; 2007 Jan 09; 37(1):26-31. PubMed ID: 17199841
    [Abstract] [Full Text] [Related]

  • 19. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY, Tang JL, Hsueh PR, Yao M, Huang SY, Chen YC, Chen YC, Shen MC, Wang CH, Tsai W, Chang SC, Tien HF, Luh KT.
    J Formos Med Assoc; 2004 Jul 09; 103(7):526-32. PubMed ID: 15318274
    [Abstract] [Full Text] [Related]

  • 20. [Bloodstream infections in children with cancer and high risk fever and neutropenia episodes in six hospitals of Santiago, Chile between 2004 and 2009].
    Solís Y, Álvarez AM, Fuentes D, de la Barra D, Avilés CL, Becker A, Salgado C, Silva P, Topelberg S, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M, Aedo S, Santolaya ME.
    Rev Chilena Infectol; 2012 Apr 09; 29(2):156-62. PubMed ID: 22689029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.